Skip to main content

  • Clinical outcomes of complex real-world diabetic patients treated with amphilimus sirolimus-eluting stents or zotarolimus-eluting stents: A single-center registry

    • Posted: 08/02/2018
    • Author:

       

      Rik Rozemeijer, Daniela Benedetto, Adriaan O. Kraaijeveld, Michiel Voskuil, ... Pieter R. Stella

       

    • 2018CRM

    Abstract

    Objective

    To assess clinical outcomes of Amphilimus Sirolimus-Eluting Stents (A-SES) as compared to Zotarolimus-Eluting Stents (ZES) in complex real-world diabetic patients.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details